Patrick Celis
Impact in
-
- Mesenchymal stem cell research
- Virus-based gene therapy research
-
- Biomedical Ethics and Regulation
Papers in
-
- Pluripotent Stem Cells Research 6
- CRISPR and Genetic Engineering 5
- Viral Infectious Diseases and Gene Expression in Insects 1
- Oncology 9
- CAR-T cell therapy research 9
- Co-authors
- Christian K. Schneider (2 shared papers)Ilona Reischl (6 shared papers)Paula Salmikangas (4 shared papers)Nicolas Ferry (3 shared papers)Egbert Flory (4 shared papers)Matthias Renner (1 shared paper)Martina Schuessler‐Lenz (3 shared papers)Dariusz Śladowski (2 shared papers)
- Journals
- Advances in experimental medicine and biology (2 papers)Human Gene Therapy (1 paper)Molecular Therapy — Methods & Clinical Development (1 paper)British Journal of Clinical Pharmacology (1 paper)Methods in enzymology on CD-ROM/Methods in enzymology (1 paper)
- Partner nations
- GermanyNetherlandsFinland
In The Last Decade
Patrick Celis
15 papers receiving 359 citations
Peers
Comparison fields: 5 of 65
- Genetics 64
- Physiology 136
- Oncology 97
- Molecular Biology 164
- Biomaterials 30
Countries citing papers authored by Patrick Celis
This map shows the geographic impact of Patrick Celis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Celis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Celis more than expected).
Fields of papers citing papers by Patrick Celis
This network shows the impact of papers produced by Patrick Celis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Celis. The network helps show where Patrick Celis may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick Celis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 160 | |
| 2 | 2015 | 50 | |
| 3 | 2017 | 40 | |
| 4 | 2015 | 36 | |
| 5 | 2017 | 25 | |
| 6 | 2012 | 16 | |
| 7 | 2010 | 12 | |
| 8 | European Regulatory guidance on virus safety of recombinant proteins, monoclonal antibodies and plasma derived medicinal products. | 2004 | 10 |
| 9 | 2011 | 9 | |
| 10 | 2023 | 6 | |
| 11 | 2015 | 5 | |
| 12 | 2024 | 2 | |
| 13 | 2025 | 1 | |
| 14 | 2018 | 1 | |
| 15 | 2015 | 1 |
About Patrick Celis
Patrick Celis is a scholar working on Molecular Biology, Oncology, Physiology, Genetics and Immunology, having authored 15 papers that have together received 374 indexed citations. Recurring topics across this work include CAR-T cell therapy research (9 papers), Biomedical Ethics and Regulation (9 papers), Pluripotent Stem Cells Research (6 papers), CRISPR and Genetic Engineering (5 papers), Virus-based gene therapy research (3 papers), Biosimilars and Bioanalytical Methods (2 papers), Viral Infectious Diseases and Gene Expression in Insects (1 paper) and Viral gastroenteritis research and epidemiology (1 paper). The work is most often cited by research in Genetics (64 citations), Physiology (136 citations), Oncology (97 citations), Molecular Biology (164 citations) and Biomaterials (30 citations). Patrick Celis has collaborated with scholars based in Germany, Netherlands and Finland. Frequent co-authors include Christian K. Schneider, Ilona Reischl, Paula Salmikangas, Nicolas Ferry, Egbert Flory, Matthias Renner, Martina Schuessler‐Lenz, Dariusz Śladowski, Bruno Sepodes and Segundo Mariz. Their work appears in journals such as Advances in experimental medicine and biology, Human Gene Therapy, Molecular Therapy — Methods & Clinical Development, British Journal of Clinical Pharmacology and Methods in enzymology on CD-ROM/Methods in enzymology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.